Aurobindo Pharma wins key FDA approval for blockbuster blood thinner in $8.5bn US market
Aurobindo Pharma gets USFDA final approval for Rivaroxaban 2.5mg and tentative nod for other doses. Find out what this means for its US market strategy. Read More
Zydus wins FDA nod for DMD drug Jaythari—what it means for rare disease treatment and its stock
Find out how Zydus Lifesciences is expanding rare disease care and investor value with USFDA-approved Jaythari tablets for Duchenne muscular dystrophy. Read More
Orchid Pharma secures USFDA approval, reinforcing global leadership in sterile cephalosporins
Orchid Pharma Limited has reaffirmed its position as a leading pharmaceutical manufacturer with the successful completion of a surprise inspection by the U.S. Food and ... Read More
Aurobindo Pharma achieves record revenue in Q3 FY25 despite profit decline
Aurobindo Pharma Limited has reported its highest-ever quarterly revenue for the third quarter of fiscal year 2025, underlining its strong position in the global pharmaceutical ... Read More
Zydus Lifesciences posts strong Q3 FY25 results with 30% net profit surge
Zydus Lifesciences Limited has reported robust financial performance for the third quarter of fiscal year 2025, driven by strong revenue growth momentum, expansion in key ... Read More
Aarti Drugs faces revenue decline amid API Market challenges in Q3 FY25
Aarti Drugs Limited, a Mumbai-based pharmaceutical company engaged in Active Pharmaceutical Ingredients (API), formulations, specialty chemicals, and intermediates, has reported a decline in revenue for ... Read More
OneSource Specialty Pharma reports stellar Q3FY25 earnings with 85% EBITDA growth, setting stage for expansion
OneSource Specialty Pharma Limited, formerly Stelis Biopharma Limited, has delivered a strong financial performance in its first full quarter post-listing. The company reported Q3FY25 revenue ... Read More
Zydus Lifesciences gets FDA approval for Phase 2b ALS trial of Usnoflast
Zydus Lifesciences, a global leader in pharmaceutical innovation, has received approval from the United States Food and Drug Administration (USFDA) to commence Phase II(b) clinical ... Read More
Glenmark Life Sciences is now Alivus Life Sciences: What this means for the pharma industry
Glenmark Life Sciences Limited, a prominent name in the pharmaceutical industry, has officially rebranded as Alivus Life Sciences Limited, marking a transformative step in its ... Read More
Aurobindo Pharma’s subsidiary Eugia secures FDA nod for pazopanib tablets
Aurobindo Pharma Limited, through its wholly owned subsidiary Eugia Pharma Specialities Limited, has received final approval from the US Food and Drug Administration (USFDA) to ... Read More